Published in Clin Exp Metastasis on January 01, 2000
Underactivation of the adiponectin-adiponectin receptor 1 axis in clear cell renal cell carcinoma: implications for progression. Clin Exp Metastasis (2013) 0.83
Prostate cancer in bone: importance of context for inhibition of matrix metalloproteinases. J Natl Cancer Inst (2002) 0.78
MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell (1998) 9.70
MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell (1999) 6.40
Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev (1999) 3.32
Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol (2000) 2.87
TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med (1998) 2.68
Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J Biol Chem (1996) 2.33
Mechanisms of bone metastasis. Cancer (1997) 2.29
Tumor cell invasion inhibited by TIMP-2. J Natl Cancer Inst (1991) 2.15
Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification. J Biol Chem (1996) 2.06
Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells. Exp Cell Res (1999) 2.06
Matrix metalloproteinases in repair. Wound Repair Regen (2000) 2.00
Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res (1993) 1.97
Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). J Cell Sci (1994) 1.86
Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res (1992) 1.70
Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12-9566 on a protracted oral daily dosing schedule in patients with solid malignancies. J Clin Oncol (2000) 1.57
Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2. J Clin Invest (1997) 1.49
Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface. Biochem J (1998) 1.48
Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption. Lab Invest (1995) 1.46
Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase. Cancer Res (1993) 1.41
Activation of NF-kappaB is involved in the survival of osteoclasts promoted by interleukin-1. J Biol Chem (1998) 1.38
Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer. Bone (1994) 1.31
High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases. Clin Cancer Res (1997) 1.30
Parathyroid hormone-related protein and bone metastases. Cancer (1997) 1.26
Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine-proteinases and matrix metalloproteinases. J Cell Physiol (1992) 1.26
Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. Int J Cancer (1994) 1.22
Prognosis of gastric carcinoma revealed by interactions between tumor cells and basement membrane. Mod Pathol (1994) 1.19
Co-culture of human breast adenocarcinoma MCF-7 cells and human dermal fibroblasts enhances the production of matrix metalloproteinases 1, 2 and 3 in fibroblasts. Br J Cancer (1995) 1.14
Tumor collagenase stimulatory factor (TCSF) expression and localization in human lung and breast cancers. J Histochem Cytochem (1997) 1.09
Human osteoblasts in culture synthesize collagenase and other matrix metalloproteinases in response to osteotropic hormones and cytokines. J Cell Sci (1992) 1.04
Interleukin-1 family expression in human breast cancer: interleukin-1 receptor antagonist. Cancer Invest (2000) 1.04
Expression of metalloproteinase-13 (Collagenase-3) is induced during fracture healing in mice. Bone (1999) 1.03
Matrix metalloproteinases in cancer: prognostic markers and targets for therapy (review). Int J Oncol (1998) 1.01
Complex roles of matrix metalloproteinases in tumor progression. Curr Top Microbiol Immunol (1996) 1.00
Expression of interleukin 6 (IL-6) correlates with oestrogen receptor in human breast carcinoma. Br J Cancer (1999) 0.98
Bone histomorphometry: standardization of nomenclature, symbols and units (summary of proposed system). Bone (1988) 0.95
Bone cells predispose bone surfaces to resorption by exposure of mineral to osteoclastic contact. J Cell Sci (1985) 0.95
Serum metalloproteinases and their inhibitors: markers for malignant potential. Br J Cancer (1994) 0.94
Review of cellular mechanisms of tumor osteolysis. Clin Orthop Relat Res (2000) 0.93
Tissue inhibitors of matrix metalloproteinases in cancer. Ann N Y Acad Sci (1999) 0.92
Production and regulation of interleukin-11 by breast cancer cells. Cancer Lett (1998) 0.87
Production of both 92- and 72-kDa gelatinases by bone cells. Matrix (1992) 0.85
Stromal degradation by the malignant epithelium in pancreatic cancer and the therapeutic potential of proteolytic inhibition. J Hepatobiliary Pancreat Surg (1998) 0.83
Tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) distribution in normal and pathological human bone. Bone (1999) 0.83
Inhibition of stimulated bone resorption in vitro by TIMP-1 and TIMP-2. Biochim Biophys Acta (1993) 0.83
Matrix-metalloproteinases and their inhibitors in plasma and tumor tissue of patients with renal cell carcinoma. Int J Cancer (2000) 0.81
Matrix metalloproteinases in multiple myeloma. Leuk Lymphoma (2000) 0.81
The synthesis of collagenase, gelatinase-A (72 kDa) and -B (95 kDa), and TIMP-1 and -2 by human osteoblasts from normal and arthritic bone. Bone (1995) 0.78
Histomorphometric analysis of osteoclastic bone resorption in metastatic bone disease from various primary malignomas. Virchows Arch A Pathol Anat Histopathol (1986) 0.76
Tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) stimulate osteoclastic bone resorption. J Bone Miner Metab (1999) 0.76
Differential expression of tissue inhibitor of metalloproteinases-2 by cutaneous squamous and basal cell carcinomas. J Invest Dermatol (1996) 0.75
Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science (1988) 11.76
Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med (1999) 8.60
Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol (1999) 7.59
Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum (1994) 3.52
Extensive condyloma lata. Br J Vener Dis (1977) 3.05
Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J Biol Chem (1992) 2.81
Cataract surgery and intraocular lens implantation in patients with uveitis. Ophthalmology (1989) 2.77
Profile of hypertension in elderly subjects. J Assoc Physicians India (2000) 2.59
Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries. Review of the general methodology. Clin Exp Rheumatol (2001) 2.55
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Risk factors for graft survival after liver transplantation from donation after cardiac death donors: an analysis of OPTN/UNOS data. Am J Transplant (2006) 2.47
Plasticity of airway cell proliferation and gene expression after acute naphthalene injury. Am J Physiol (1995) 2.45
Sequence analysis of cDNAs for the human and bovine ATP synthase beta subunit: mitochondrial DNA genes sustain seventeen times more mutations. Curr Genet (1987) 2.42
Treatment of neurocysticercosis: current status and future research needs. Neurology (2006) 2.41
cis-acting elements that confer lung epithelial cell expression of the CC10 gene. J Biol Chem (1992) 2.18
The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family. Cell (1989) 2.07
Earlobe reconstruction using a Limberg flap in six ears. Br J Plast Surg (2003) 2.07
Running and the development of disability with age. Ann Intern Med (1994) 2.05
Diffusion weighted MR imaging of 5-fluorouracil and oxaliplatin-induced leukoencephalopathy. J Postgrad Med (2013) 2.05
The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia. Ann Intern Med (1997) 2.00
Embryonic mouse lung epithelial progenitor cells co-express immunohistochemical markers of diverse mature cell lineages. J Histochem Cytochem (1996) 1.92
Uncommon presentations of neurocysticercosis. J Neurol Sci (1998) 1.75
Reduction in long-term disability in patients with rheumatoid arthritis by disease-modifying antirheumatic drug-based treatment strategies. Arthritis Rheum (1996) 1.73
Drug abuse in Punjab. Br J Addict Alcohol Other Drugs (1979) 1.71
Arteriovenous malformation of knee masquerading as juvenile arthritis. Scand J Rheumatol (1998) 1.65
Sciatic nerve division: a cadaver study in the Indian population and review of the literature. Singapore Med J (2010) 1.65
Mutant human presenilin 1 protects presenilin 1 null mouse against embryonic lethality and elevates Abeta1-42/43 expression. Neuron (1998) 1.64
Subtenons infection by Dirofilaria repens. Indian J Med Microbiol (2006) 1.62
Brief overview of maternal triglycerides as a risk factor for pre-eclampsia. BJOG (2006) 1.59
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Changing pattern of antibiotic sensitivity of Salmonella typhi. Natl Med J India (1999) 1.51
Drugs on a medical campus I. Drug use among medical undergraduates. Drug Alcohol Depend (1979) 1.51
Local recurrence and survival among black women with early-stage breast cancer treated with breast-conservation therapy or mastectomy. Ann Surg Oncol (1999) 1.50
Post-prandial hypertriglyceridemia in patients with type 2 diabetes mellitus with and without macrovascular disease. J Assoc Physicians India (2010) 1.49
The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades. Oncogene (1996) 1.48
Interactions between heterologous FtsA and FtsZ proteins at the FtsZ ring. J Bacteriol (1997) 1.45
Leprosy presenting as macrocheilia. Indian J Lepr (2000) 1.43
Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritis. Arthritis Rheum (1990) 1.43
Milk of calcium in the inferior calyx of a hydronephrotic kidney in a tetraplegic patient - a diagnosis to be made before scheduling for extracorporeal shock wave lithotripsy. Spinal Cord (2000) 1.41
Profile of HLA-B27-related 'unclassifiable' seronegative spondyloarthropathy in females and its comparison with the profile in males. Br J Rheumatol (1995) 1.41
Uteroglobin/Clara cell 10-kDa family of proteins: nomenclature committee report. Ann N Y Acad Sci (2000) 1.41
Extracting insights from the shape of complex data using topology. Sci Rep (2013) 1.40
The natural history of ankylosing spondylitis: is the disease really changing? J Rheumatol (1989) 1.40
Bilateral acetazolamide-induced choroidal effusion following cataract surgery. Eye (Lond) (2007) 1.40
The laryngeal mask airway and the Guedel airway. Anaesthesia (1994) 1.39
Botulinum toxin in the treatment of dystonias--a hospital based study. J Assoc Physicians India (2003) 1.39
Extra corporeal shock wave lithotripsy of calculi located in lower calyx of left kidney in a spinal cord injury patient who has implantation of baclofen pump in the ipsilateral loin. Spinal Cord (2002) 1.39
Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK. Br J Cancer (2013) 1.39
Pemphigus herpetiformis. Int J Dermatol (1990) 1.38
Role of botulinum toxin in treatment of achalasia cardia. Indian J Gastroenterol (1996) 1.38
Gsh-1: a novel murine homeobox gene expressed in the central nervous system. Dev Dyn (1995) 1.37
The quality of obstetrical clinical practice guidelines promulgated by a specialty society. J Obstet Gynaecol Can (2002) 1.37
Ontogeny of Clara cell-specific protein and its mRNA: their association with neuroepithelial bodies in human fetal lung and in bronchopulmonary dysplasia. J Histochem Cytochem (1996) 1.32
Distinct genomic copy number in mitochondria of different mammalian organs. J Cell Physiol (1990) 1.30
Conformational mutations in human mitochondrial DNA. Nature (1987) 1.29
Erythromycin for BCG cold abscess. Lancet (1984) 1.29
Therapeutic keratoplasty in Pseudomonas pyocyaneus corneal ulcers. Br J Ophthalmol (1971) 1.29
Tissue-specific expression, hormonal regulation and 5'-flanking gene region of the rat Clara cell 10 kDa protein: comparison to rabbit uteroglobin. Nucleic Acids Res (1990) 1.27
Tubercular fistula in ano. Br J Surg (1988) 1.27
Discordance between receptor status in primary and metastatic breast cancer: an exploratory study of bone and bone marrow biopsies. Clin Oncol (R Coll Radiol) (2008) 1.26
Lower levels of occupation, income and education are strongly associated with a longer smoking duration: multivariate results from the 2001 Australian National Drug Strategy Survey. Public Health (2005) 1.26
Gsh-4 encodes a LIM-type homeodomain, is expressed in the developing central nervous system and is required for early postnatal survival. EMBO J (1994) 1.25
Leber's disease and dystonia: a mitochondrial disease. Neurology (1986) 1.25
Scavenging of extracellular H2O2 by catalase inhibits the proliferation of HER-2/Neu-transformed rat-1 fibroblasts through the induction of a stress response. J Biol Chem (2000) 1.25
Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 1.23
Comment on "Pitfall in insertion of suprapubic catheter in patients with spinal cord injury". Spinal Cord (2003) 1.23
Vitiligo and blood groups. Preliminary report. Br J Dermatol (1966) 1.22
Neonatal intestinal obstruction with isolated levocardia. J Pediatr Surg (2000) 1.19
Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19
Azimuthal anisotropy of charged particles at high transverse momenta in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2012) 1.19
Human subcutaneous dirofilariasis in India: a report of three cases with brief review of literature. Indian J Med Microbiol (2010) 1.19
Mortality and cause of death in Japanese patients with rheumatoid arthritis based on a large observational cohort, IORRA. Scand J Rheumatol (2010) 1.18
Accumulation of human promyelocytic leukemic (HL-60) cells at two energetic cell cycle checkpoints. Cancer Res (1995) 1.18
Nutritional treatment for acquired immunodeficiency virus-associated wasting using beta-hydroxy beta-methylbutyrate, glutamine, and arginine: a randomized, double-blind, placebo-controlled study. JPEN J Parenter Enteral Nutr (2000) 1.18
Improvement in glucose tolerance due to Momordica charantia (karela). Br Med J (Clin Res Ed) (1981) 1.16
Prevalence and risk factors for female sexual dysfunction in women attending a medical clinic in south India. J Postgrad Med (2009) 1.13
Study of clinical, biochemical and immunological factors determining stability of disease in patients with generalized vitiligo undergoing melanocyte transplantation. Br J Dermatol (2012) 1.13
Long-term morbidity, mortality, and economics of rheumatoid arthritis. Arthritis Rheum (2001) 1.13
Presence or absence of lipopolysaccharide O antigens affects type III secretion by Pseudomonas aeruginosa. J Bacteriol (2007) 1.12
An immunologic study of the secretory products of rat Clara cells. J Histochem Cytochem (1984) 1.12
Status of birth preparedness & complication readiness in Rewa District of Madhya Pradesh. Indian J Public Health (2010) 1.11
Search for a W' or techni-ρ decaying into WZ in pp Collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2012) 1.10
A toxicity index for comparison of side effects among different drugs. Arthritis Rheum (1990) 1.10
Experience with a trigger tool for identifying adverse drug events among older adults in ambulatory primary care. Qual Saf Health Care (2009) 1.10
Transforming growth factor beta1 acts as an inducer of matrix metalloproteinase expression and activity in human bone-metastasizing cancer cells. Clin Exp Metastasis (1999) 1.10
Silent hydronephrosis/pyonephrosis due to upper urinary tract calculi in spinal cord injury patients. Spinal Cord (2000) 1.09
Variations in the origins of the profunda femoris, medial and lateral femoral circumflex arteries: a cadaver study in the Indian population. Rom J Morphol Embryol (2010) 1.09
Search for new physics with same-sign isolated dilepton events with jets and missing transverse energy. Phys Rev Lett (2012) 1.09
Community-care waiting list for persons with spinal cord injury. Spinal Cord (2001) 1.08
Alveolar adenoma: a histochemical, immunohistochemical, and ultrastructural analysis of 17 cases. Hum Pathol (1999) 1.08
Acute renal failure following consumption of raw fish gall-bladder from Manipur. J Assoc Physicians India (2004) 1.08
Human ovarian cancer ascites fluid contains a mixture of incompletely degraded soluble products of fibrin that collectively possess an antiangiogenic property. Int J Gynecol Cancer (2006) 1.07
Teratogenicity of Asparagus racemosus Willd. root, a herbal medicine. Indian J Exp Biol (2006) 1.07
Use of tetracycline as an inhibitor of matrix metalloproteinase activity secreted by human bone-metastasizing cancer cells. Invasion Metastasis (1997) 1.07
Biochemical changes in blood in cases of acute copper sulphate poisoning. J Indian Med Assoc (1968) 1.06
Racial and gender differences in endothelin-1. Am J Cardiol (1996) 1.06
An extraintestinal, pathogenic isolate of Escherichia coli (O4/K54/H5) can produce a group 1 capsule which is divergently regulated from its constitutively produced group 2, K54 capsular polysaccharide. J Bacteriol (1993) 1.06